Phoenix and Raven Offer Eligible Canadians Ozempic® at the Same Price as Generic Semaglutide

Phoenix and Raven Offer Eligible Canadians Ozempic® at the Same Price as Generic Semaglutide

The digital health providers are giving Canadians a real choice: Brand-name Ozempic® at the same starting price at $124.99 as generic semaglutide

Phoenix and Raven, Canada’s leading digital health providers, announced today that eligible Canadians can now access Ozempic® through their platforms at the same starting $124.99 price as generic semaglutide, giving patients paying out of pocket the freedom to choose based on what’s right for them clinically, without cost being the deciding factor.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260529609600/en/

“Last week, we made a commitment to Canadians by leading on competitive pricing for generic semaglutide, and today, we’re proud to go further, extending that same commitment to patients choosing Ozempic®,” said Kevin Bache Founder and Co-CEO at Phoenix and Raven. “We’ve turned our promise of accessible, affordable care into reality for patients from coast to coast. Phoenix and Raven are setting a new standard for what Canadian telehealth companies can and should do for patients across the country.”